Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09LVY
|
|||
Former ID |
DNC013519
|
|||
Drug Name |
9-mercapto-8-oxo-N-phenylnonanamide
|
|||
Synonyms |
CHEMBL402451
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H21NO2S
|
|||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)CS
|
|||
InChI |
1S/C15H21NO2S/c17-14(12-19)10-6-1-2-7-11-15(18)16-13-8-4-3-5-9-13/h3-5,8-9,19H,1-2,6-7,10-12H2,(H,16,18)
|
|||
InChIKey |
UJRMRSNAFIQQLD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histone deacetylase 8 (HDAC8) | Target Info | Inhibitor | [1] |
KEGG Pathway | Alcoholism | |||
Viral carcinogenesis | ||||
Panther Pathway | Wnt signaling pathway | |||
Pathway Interaction Database | Signaling events mediated by HDAC Class I | |||
Reactome | NOTCH1 Intracellular Domain Regulates Transcription | |||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | ||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | ||||
HDACs deacetylate histones | ||||
WikiPathways | Integrated Pancreatic Cancer Pathway | |||
Neural Crest Differentiation | ||||
Cell Cycle |
References | Top | |||
---|---|---|---|---|
REF 1 | Histone deacetylase inhibitors: from bench to clinic. J Med Chem. 2008 Mar 27;51(6):1505-29. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.